about
Th1 Platform Immune Responses Against Leishmania major Induced by Thiol-Specific Antioxidant-Based DNA VaccinesInterferon-gamma and interlukin-4 patterns in BALB/c mice suffering from cutaneous leishmaniasis treated with cantharidin.Identification of Candida Species Using MP65 Gene and Evaluation of the Candida albicans MP65 Gene Expression in BALB/C Mice.Identification of HCV genotypes in HCV infected blood donorsPrevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.Correlation between viral load of HBV in chronic hepatitis B patients and precore and Basal core promoter mutationsApoptotic activity and anti-Toxoplasma effects of artemether on the tachyzoites and experimental infected Vero and J774 cell lines by Toxoplasma gondii.Genetic Variants of Cytochrome b-245, Alpha Polypeptide Gene and Premature Acute Myocardial Infarction Risk in an Iranian Population.Torque teno virus and hepatitis C virus co-infection in Iranian pediatric thalassemia patients.Distinct Toll-like Receptor 3 and 7 Expression in Peripheral Blood Mononuclear Cells From Patients with Chronic Hepatitis C Infection.Cloning and Constructing a Plasmid Encoding Leishmania Eukaryotic Initiation Factor Gene of Leishmania major Fused with Green Fluorescent Protein Gene as a Vaccine Candidate.Association of miR-146a rs2910164 and miR-149 rs2292832 Variants with Susceptibility to Type 2 Diabetes.Overexpression of miR-183/-96/-182 triggers neuronal cell fate in Human Retinal Pigment Epithelial (hRPE) cells in culture.Comparative Assessment of Induced Immune Responses Following Intramuscular Immunization with Fusion and Cocktail of LeIF, LACK and TSA Genes Against Cutaneous Leishmaniasis in BALB/c Mice.Immunogenicity and efficacy of a bivalent DNA vaccine containing LeIF and TSA genes against murine cutaneous leishmaniasis.Impaired Akt phosphorylation in B-cells of patients with common variable immunodeficiency.Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection.The Usefulness of Anti-HCV Signal to Cut-off Ratio in Predicting Viremia in Anti-HCV in Patients With Hepatitis C Virus Infection.Evaluation of protective effect of IL-22 and IL-12 on cutaneous leishmaniasis in BALB/c mice.Quantitative polymerase chain reaction for detection of human herpesvirus-7 infection in umbilical cord blood donors.Analysis of Immumoreactivity of Heterologously Expressed Non-structural Protein 4B (NS4B) from Hepatitis C Virus (HCV) Genotype 1a.Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1.Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.Clinical outcomes of Torque teno virus-infected thalassemic patients with and without hepatitis C virus infection.SEN virus detection in thalassemic patients infected with hepatitis C virus.Effect of IL-22 on DNA vaccine encoding LACK gene of Leishmania major in BALB/c mice.The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.Vitronectin and Urokinase-Type Plasminogen Activator Gene Expression Levels Are Increased in Patients with Coronary Artery In-Stent Restenosis.Study of hepatitis B prevalence in parallel with the most frequent HBV genotype in South Iranian blood donors.HLA-DRB1*15:03 and HLA-DRB1*11: useful predictive alleles for alloantibody production in thalassemia patients.Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii.Phylogenetic analysis of HTLV-1 in Iranian blood donors, HIV-1 positive patients and patients with beta thalassemia.Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, IranCommunication of substance P, calcitonin-gene-related neuropeptides and chemokine receptor 4 (CXCR4) in cord blood hematopoietic stem cellsRhoptry antigens as vaccine targetEvaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c miceEvaluation of the immune response induced by DNA vaccine cocktail expressing complete SAG1 and ROP2 genes against toxoplasmosisProduction of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity techniqueEnhancement of immune response induced by DNA vaccine cocktail expressing complete LACK and TSA genes against Leishmania major
P50
Q34068700-F7B06A21-2ADA-41CE-8A88-B95BECC86D19Q34443494-43BA3728-E162-4ABB-9CAB-B0A9741B16C7Q35690934-55E38BA2-7E6D-4BD9-8D44-C05A697143EEQ36255746-44AAED49-4873-4BD9-A021-038DEC6A591AQ36654281-E6F109C2-E3FB-4C41-AAA7-DE463E02492EQ36771263-28E135D2-F806-4615-99FF-21A0248C37BDQ36780211-BFA041E8-A3FE-44FD-878B-9D437ACB4A0DQ37041329-BEA0CF80-A600-405B-86AC-5019CE872421Q38756951-F82106D8-8F90-4167-9D2A-C76091ADCE11Q38799684-4A132120-35C7-470F-AD60-7E14E9065E71Q38930694-F722C12F-4019-4135-9909-064D64391E40Q38977368-C6CA12E4-E19C-4625-954A-82B7DD5CB96CQ39104195-47041367-6D71-499D-9439-6BC483E4CEE6Q40105761-948892A6-659C-46A3-9919-61DEB3A63397Q40319505-D6AE09FE-BBB4-49B3-9E52-43033A6AF08AQ40528656-58F6360D-3C0F-423D-B5AA-F6F28FF485E7Q40794947-602D4C71-C341-42C2-B665-416E09E04B93Q40902779-970D44CE-5937-4B01-AABB-427EA928EB97Q41190371-261F1AE0-B525-467B-B435-B786F89E86F7Q41614837-E97932BE-046B-4179-A357-714B88C9D299Q41640169-0F91171C-5FB3-4791-A533-27D9FDF9E454Q41674324-4C14C06A-5B74-4432-BB68-72A55A1CC25EQ42236714-8671BF68-8BCC-43C2-98E2-6BF0D4E5D573Q42282002-20580631-5C14-4778-98FC-6F5DF6CC628BQ42784988-D72087F6-B3C1-48EC-8C94-8044E026A9CBQ42983431-0EBF2729-83FC-4070-B7B9-13DF3E356253Q43471186-1BF80CC8-5513-41CC-99A6-8C0441FDDA2DQ48147993-822C240A-9341-477A-982D-F5D62ACE4042Q49984918-2B49321F-E26E-4F01-9918-9E5B8DFA2E23Q51198020-6C0E6227-F4F8-48D1-A95D-8D3A82070A73Q52565161-A5706E20-EB50-45B6-A829-10657E5C4523Q54226086-6A123D31-F6FF-46C7-91BE-33D12196F27EQ55239065-3FD24F8F-487F-4634-A37B-DF313DBFBF11Q59354010-83CE3568-5649-43AA-8ADA-7D44C2FA1E45Q60981467-EBC24FE4-3192-4ECC-8996-414E43455DA8Q61804925-32376AEB-BBD5-4D11-AF8A-E88427AD9693Q64235017-3113538A-89AF-41FE-A155-F5145B345EA5Q82542549-D87F81DF-98EC-4BCB-B997-F3924F2CB26FQ84513410-809AEA72-874D-44DD-924B-D9E8A4F4E526Q87403899-BC6A9D52-FE5A-4E87-BC45-11616C4A4682
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Z Sharifi
@en
Z Sharifi
@nl
type
label
Z Sharifi
@en
Z Sharifi
@nl
prefLabel
Z Sharifi
@en
Z Sharifi
@nl
P31
P496
0000-0002-6600-910X